Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA general NIH announcement about terminology changes appears above the ClinicalTrials.gov navigation, and the site revision advances from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page. Its footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check44 days agoChange DetectedCore study details and associated metadata were removed from the page, including design and eligibility information and listed locations. This reduces visible information about how the study is conducted and where it takes place.SummaryDifference19%

- Check51 days agoChange DetectedRevision: v3.7.0 replaces Revision: v3.6.6 in the Study Record Dates, signaling an update to the study record's revision tag. This appears to be an administrative update rather than changing core trial data visible to users.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a small site update without changes to the study details or visible content.SummaryDifference0.0%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.